1
|
Marcuzzi D, Toigo V, Boldrin M, Chitarin G, Dal Bello S, Grando L, Luchetta A, Pasqualotto R, Pavei M, Serianni G, Zanotto L, Agnello R, Agostinetti P, Agostini M, Aprile D, Barbisan M, Battistella M, Berton G, Bigi M, Brombin M, Candela V, Candeloro V, Canton A, Casagrande R, Cavallini C, Cavazzana R, Cordaro L, Cruz N, Dalla Palma M, Dan M, De Lorenzi A, Delogu R, De Muri M, De Nardi M, Denizeau S, Fadone M, Fellin F, Ferro A, Gaio E, Gasparrini C, Gnesotto F, Jain P, La Rosa A, Lopez-Bruna D, Lorenzini R, Maistrello A, Manduchi G, Manfrin S, Marconato N, Mario I, Martini G, Milazzo R, Patton T, Peruzzo S, Pilan N, Pimazzoni A, Poggi C, Pomaro N, Pouradier-Duteil B, Recchia M, Rigoni-Garola A, Rizzetto D, Rizzolo A, Santoro F, Sartori E, Segalini B, Shepherd A, Siragusa M, Sonato P, Sottocornola A, Spada E, Spagnolo S, Spolaore M, Taliercio C, Tinti P, Tomsič P, Trevisan L, Ugoletti M, Valente M, Valisa M, Veronese F, Vignando M, Zaccaria P, Zagorski R, Zaniol B, Zaupa M, Zuin M, Cavenago M, Boilson D, Rotti C, Decamps H, Geli F, Sharma A, Veltri P, Zacks J, Simon M, Paolucci F, Garbuglia A, Gutierrez D, Masiello A, Mico G, Labate C, Readman P, Bragulat E, Bailly-Maitre L, Gomez G, Kouzmenko G, Albajar F, Kashiwagi M, Tobari H, Kojima A, Murayama M, Hatakeyama S, Oshita E, Maejima T, Shibata N, Yamashita Y, Watanabe K, Singh N, Singh M, Dhola H, Fantz U, Heinemann B, Wimmer C, Wünderlich D, Tsumori K, Croci G, Gorini G, Muraro A, Rebai M, Tardocchi M, Giacomelli L, Rigamonti D, Taccogna F, Bruno D, Rutigliano M, Longo S, Deambrosis S, Miorin E, Montagner F, Tonti A, Panin F. Lessons learned after three years of SPIDER operation and the first MITICA integrated tests. Fusion Engineering and Design 2023. [DOI: 10.1016/j.fusengdes.2023.113590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/27/2023]
|
2
|
Perugini E, Guelbeogo WM, Guglielmo F, Poggi C, Gabrieli E, Ranson H, Della Torre A, Pombi M. The interplay between malaria vectors and human activity accounts for high residual malaria transmission in a Burkina Faso village with universal ITN coverage. Parasit Vectors 2023; 16:101. [PMID: 36922855 PMCID: PMC10015820 DOI: 10.1186/s13071-023-05710-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Accepted: 02/22/2023] [Indexed: 03/17/2023] Open
Abstract
BACKGROUND Mosquito and human behaviour interaction is a key determinant of the maximum level of protection against malaria that can be provided by insecticide-treated nets (ITNs). Nevertheless, scant literature focuses on this interaction, overlooking a fundamental factor for efficient malaria control. This study aims to estimate malaria transmission risk in a Burkina Faso village by integrating vector biting rhythms with some key information about human habits. METHODS Indoor/outdoor human landing catches were conducted for 16 h (16:00-08:00) during 8 nights (September 2020) in Goden village. A survey about net usage and sleeping patterns was submitted to half the households (October-December 2020). A subsample of collected specimens of Anopheles gambiae sensu lato was molecularly processed for species identification, Plasmodium detection from heads-thoraxes and L1014F pyrethroid-resistance allele genotyping. Hourly mosquito abundance was statistically assessed by GLM/GAM, and the entomological inoculation rate (EIR) was corrected for the actual ITN usage retrieved from the questionnaire. RESULTS Malaria transmission was mainly driven by Anopheles coluzzii (68.7%) followed by A. arabiensis (26.2%). The overall sporozoite rate was 2% with L1014F estimated frequency of 0.68 (N = 1070 out of 15,201 A. gambiae s.l. collected). No major shift in mosquito biting rhythms in response to ITN or differences between indoor and outdoor catches were detected. Impressive high biting pressure (mean 30.3 mosquitoes/person/hour) was exerted from 20:00 to 06:00 with a peak at 4:00. Human survey revealed that nearly all inhabitants were awake before 20:00 and after 7:00 and at least 8.7% had no access to bednets. Adjusting for anthropological data, the EIR dropped from 6.7 to 1.2 infective bites/person/16 h. In a scenario of full net coverage and accounting only for the human sleeping patterns, the daily malaria transmission risk not targetable by ITNs was 0.69 infective bites. CONCLUSIONS The high mosquito densities and interplay between human/vector activities means that an estimated 10% of residual malaria transmission cannot be prevented by ITNs in the village. Locally tailored studies, like the current one, are essential to explore the heterogeneity of human exposure to infective bites and, consequently, to instruct the adoption of new vector control tools strengthening individual and community protection.
Collapse
Affiliation(s)
- Eleonora Perugini
- Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy
| | - Wamdaogo M Guelbeogo
- Centre National de Recherche et Formation sur le Paludisme, Ouagadougou, Burkina Faso
| | - Federica Guglielmo
- Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK
| | - Cristiana Poggi
- Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy
| | - Eugenio Gabrieli
- Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy
| | - Hilary Ranson
- Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK
| | | | - Marco Pombi
- Department of Public Health and Infectious Diseases, Sapienza University, Rome, Italy.
| |
Collapse
|
3
|
Agnello R, Barbisan M, Pasqualotto R, Pimazzoni A, Poggi C, Sartori E, Serianni G. Measurement of stripping losses in the negative ion source SPIDER. Fusion Engineering and Design 2023. [DOI: 10.1016/j.fusengdes.2022.113350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
4
|
Serianni G, Sartori E, Agnello R, Agostinetti P, Agostini M, Barbisan M, Brombin M, Candeloro V, Dalla Palma M, Delogu R, De Muri M, Fadone M, Mario I, Patton T, Pimazzoni A, Poggi C, Pouradier-Duteil B, Segalini B, Shepherd A, Spolaore M, Taliercio C, Ugoletti M, Veltri P, Zaniol B, Pasqualotto R. Spatially resolved diagnostics for optimization of large ion beam sources. Rev Sci Instrum 2022; 93:081101. [PMID: 36050050 DOI: 10.1063/5.0084797] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/10/2022] [Accepted: 07/27/2022] [Indexed: 06/15/2023]
Abstract
Giant negative ion sources for neutral beam injectors deliver huge negative ion currents, thanks to their multi-beamlet configuration. As the single-beamlet optics defines the transmission losses along the beamline, the extraction of a similar current for all beamlets is extremely desirable, in order to facilitate the beam source operation (i.e., around perveance match). This Review investigates the correlation between the vertical profile of beam intensity and the vertical profiles of plasma properties at the extraction region of the source, focusing on the influence of increasing cesium injection. Only by the combined use of all available source diagnostics, described in this Review, can beam features on the scale of the non-uniformities be investigated with a sufficient space resolution. At RF power of 50 kW/driver, with intermediate bias currents and a filter field of 2.4 mT, it is found that the central part of the four vertical beam segments exhibits comparable plasma density and beamlet currents; at the edges of the central segments, both the beam and electron density appear to decrease (probably maintaining fixed electron-to-ion ratio); at the bottom of the source, an increase of cesium injection can compensate for the vertical drifts that cause a much higher presence of electrons and a lower amount of negative ions.
Collapse
Affiliation(s)
- G Serianni
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - E Sartori
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - R Agnello
- Ecole Polytechnique Fédérale de Lausanne (EPFL), Swiss Plasma Center (SPC), 1015 Lausanne, Switzerland
| | - P Agostinetti
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Agostini
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Barbisan
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Brombin
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - V Candeloro
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Dalla Palma
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - R Delogu
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M De Muri
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Fadone
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - I Mario
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - T Patton
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - A Pimazzoni
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - C Poggi
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - B Pouradier-Duteil
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - B Segalini
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - A Shepherd
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Spolaore
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - C Taliercio
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Ugoletti
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - P Veltri
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067, St. Paul-lez-Durance, France
| | - B Zaniol
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - R Pasqualotto
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| |
Collapse
|
5
|
Bernardini I, Poggi C, Manzi S, Bezerra-Santos MA, Beugnet F, Fourie J, Otranto D, Pombi M. Laboratory breeding of two Phortica species (Diptera: Drosophilidae), vectors of the zoonotic eyeworm Thelazia callipaeda. Parasit Vectors 2022; 15:200. [PMID: 35698211 PMCID: PMC9195204 DOI: 10.1186/s13071-022-05331-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2022] [Accepted: 05/22/2022] [Indexed: 11/17/2022] Open
Abstract
Background Some species of drosophilid flies belonging to the genus Phortica feed on ocular secretions of mammals, acting as biological vectors of the zoonotic eyeworm Thelazia callipaeda. This study describes an effective breeding protocol of Phortica variegata and Phortica oldenbergi in insectary conditions. Methods Alive gravid flies of P. oldenbergi, P. variegata and Phortica semivirgo were field collected in wooded areas of Lazio region (Italy) and allowed to oviposit singularly to obtain isofamilies. Flies were maintained in ovipots (200 ml) with a plaster-covered bottom to maintain high humidity level inside. Adult feeding was guaranteed by fresh apples and a liquid dietary supplement containing sodium chloride and mucin proteins, while larval development was obtained by Drosophila-like agar feeding medium. The breeding performances of two media were compared: a standard one based on cornmeal flour and an enriched medium based on chestnut flour. All conditions were kept in a climatic chamber with a photoperiod of 14:10 h light:dark, 26 ± 2 °C and 80 ± 10% RH. Results From a total of 130 field-collected Phortica spp., three generations (i.e. F1 = 783, F2 = 109, F3 = 6) were obtained. Phortica oldenbergi was the species with highest breeding performance, being the only species reaching F3. Chestnut-based feeding medium allowed higher adult production and survival probability in both P. oldenbergi and P. variegata. Adult production/female was promising in both species (P. oldenbergi: 13.5 F1/f; P. variegata: 4.5 F1/f). Conclusions This standardized breeding protocol, based on controlled climatic parameters and fly densities, together with the introduction of an enriched chestnut-based feeding medium, allowed to investigate aspects of life history traits of Phortica spp. involved in the transmission of T. callipaeda. Obtaining F3 generation of these species for the first time paved the road for the establishment of stable colonies, an essential requirement for future studies on these vectors in controlled conditions. Graphical abstract ![]()
Collapse
Affiliation(s)
- Ilaria Bernardini
- Dipartimento Di Malattie Infettive, Istituto Superiore Di Sanità, Rome, Italy.,Dipartimento Di Sanità Pubblica E Malattie Infettive, Sapienza Università Di Roma, Rome, Italy
| | - Cristiana Poggi
- Dipartimento Di Sanità Pubblica E Malattie Infettive, Sapienza Università Di Roma, Rome, Italy
| | - Sara Manzi
- Dipartimento Di Sanità Pubblica E Malattie Infettive, Sapienza Università Di Roma, Rome, Italy
| | | | | | | | - Domenico Otranto
- Dipartimento Di Medicina Veterinaria, Università Degli Studi Di Bari, Valenzano, Italy
| | - Marco Pombi
- Dipartimento Di Sanità Pubblica E Malattie Infettive, Sapienza Università Di Roma, Rome, Italy.
| |
Collapse
|
6
|
Sartori E, Brombin M, Laterza B, Zuin M, Cavazzana R, Cervaro V, Degli Agostini F, Fadone M, Fasolo D, Grando L, Jain P, Kisaki M, Maistrello A, Moro G, Pimazzoni A, Poggi C, Segalini B, Shepherd A, Spolaore M, Taliercio C, Tollin M, Ugoletti M, Veltri P, Zamengo A, Serianni G. Development of a set of movable electrostatic probes to characterize the plasma in the ITER neutral beam negative-ion source prototype. Fusion Engineering and Design 2021. [DOI: 10.1016/j.fusengdes.2021.112424] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
7
|
Toigo V, Marcuzzi D, Serianni G, Boldrin M, Chitarin G, Bello SD, Grando L, Luchetta A, Pasqualotto R, Zaccaria P, Zanotto L, Agnello R, Agostinetti P, Agostini M, Antoni V, Aprile D, Barbisan M, Battistella M, Berton G, Bigi M, Brombin M, Candeloro V, Canton A, Casagrande R, Cavallini C, Cavazzana R, Cordaro L, Cruz N, Palma MD, Dan M, De Lorenzi A, Delogu R, De Muri M, Denizeau S, Fadone M, Fellin F, Ferro A, Gaio E, Gasparini F, Gasparrini C, Gnesotto F, Jain P, Krastev P, Lopez-Bruna D, Lorenzini R, Maistrello A, Manduchi G, Manfrin S, Marconato N, Martines E, Martini G, Martini S, Milazzo R, Patton T, Pavei M, Peruzzo S, Pilan N, Pimazzoni A, Poggi C, Pomaro N, Pouradier-Duteil B, Recchia M, Rigoni-Garola A, Rizzolo A, Sartori E, Shepherd A, Siragusa M, Sonato P, Sottocornola A, Spada E, Spagnolo S, Spolaore M, Taliercio C, Terranova D, Tinti P, Tomsič P, Trevisan L, Ugoletti M, Valente M, Vignando M, Zagorski R, Zamengo A, Zaniol B, Zaupa M, Zuin M, Cavenago M, Boilson D, Rotti C, Veltri P, Decamps H, Dremel M, Graceffa J, Geli F, Urbani M, Zacks J, Bonicelli T, Paolucci F, Garbuglia A, Agarici G, Gomez G, Gutierrez D, Kouzmenko G, Labate C, Masiello A, Mico G, Moreno JF, Pilard V, Rousseau A, Simon M, Kashiwagi M, Tobari H, Watanabe K, Maejima T, Kojima A, Oshita E, Yamashita Y, Konno S, Singh M, Chakraborty A, Patel H, Singh N, Fantz U, Bonomo F, Cristofaro S, Heinemann B, Kraus W, Wimmer C, Wünderlich D, Fubiani G, Tsumori K, Croci G, Gorini G, McCormack O, Muraro A, Rebai M, Tardocchi M, Giacomelli L, Rigamonti D, Taccogna F, Bruno D, Rutigliano M, D'Arienzo M, Tonti A, Panin F. On the road to ITER NBIs: SPIDER improvement after first operation and MITICA construction progress. Fusion Engineering and Design 2021. [DOI: 10.1016/j.fusengdes.2021.112622] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
8
|
Poggi C, Sartori E, Zuin M, Brombin M, Cervaro V, Fadone M, Fassina A, Fincato M, Segalini B, Serianni G. Publisher's Note: "CRISP: A compact RF ion source prototype for emittance scanner testing" [Rev. Sci. Instrum. 91, 033314 (2020)]. Rev Sci Instrum 2020; 91:069902. [PMID: 32611007 DOI: 10.1063/5.0015273] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/15/2020] [Indexed: 06/11/2023]
Affiliation(s)
- C Poggi
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - E Sartori
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - M Zuin
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - M Brombin
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - V Cervaro
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - M Fadone
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - A Fassina
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - M Fincato
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - B Segalini
- Università degli Studi di Padova, Via 8 Febbraio 1848, 2, 35122 Padova PD, Italy
| | - G Serianni
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| |
Collapse
|
9
|
Poggi C, Sartori E, Zuin M, Brombin M, Cervaro V, Fadone M, Fassina A, Fincato M, Segalini B, Serianni G. CRISP: A compact RF ion source prototype for emittance scanner testing. Rev Sci Instrum 2020; 91:033314. [PMID: 32259950 DOI: 10.1063/1.5129641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/30/2019] [Accepted: 02/25/2020] [Indexed: 06/11/2023]
Abstract
A movable Allison type emittance scanner is being developed to characterize the phase-space distribution of the beamlets of spectral phase interferometry for direct electric-field reconstruction, the prototype RF negative ion source of the ITER heating neutral beam injector. To test the electronics and verify the capability of the device to resolve nearby beamlets, a compact RF ion source prototype has been set up, capable of accelerating 1 mA of helium ions up to a voltage of 2 kV. A commercial 100 W RF generator creates a plasma inside a Pyrex tube, with a density between 1015 and 1016 m-3 and an electron temperature up to 15 eV. Three multi-aperture grids in accel-decel configuration extract and accelerate the ions, which are measured with a Faraday cup. We present in this paper the characterization of the ion source and its first operation, showing that it is suitable for the commissioning of the Allison scanner.
Collapse
Affiliation(s)
- C Poggi
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - E Sartori
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - M Zuin
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - M Brombin
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - V Cervaro
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - M Fadone
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - A Fassina
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - M Fincato
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| | - B Segalini
- Università degli Studi di Padova, Via 8 Febbraio 1848, 2, 35122 Padova PD, Italy
| | - G Serianni
- Consorzio RFX (CNR, ENEA, INFN, Università di Padova, Acciaierie Venete S.p.A.), C. Stati Uniti 4, 35127 Padova, Italy
| |
Collapse
|
10
|
Serianni G, Toigo V, Bigi M, Boldrin M, Chitarin G, Dal Bello S, Grando L, Luchetta A, Marcuzzi D, Pasqualotto R, Pomaro N, Zaccaria P, Zanotto L, Agostinetti P, Agostini M, Antoni V, Aprile D, Barbisan M, Battistella M, Brombin M, Canton A, Cavazzana R, Dalla Palma M, Dan M, Delogu R, De Lorenzi A, De Muri M, Denizeau S, Fadone M, Fellin F, Ferro A, Gaio E, Gambetta G, Gasparini F, Gnesotto F, Jain P, Maistrello A, Manduchi G, Manfrin S, Marchiori G, Marconato N, Moresco M, Patton T, Pavei M, Peruzzo S, Pilan N, Pimazzoni A, Piovan R, Poggi C, Recchia M, Rigoni A, Rizzolo A, Rostagni G, Sartori E, Siragusa M, Sonato P, Spada E, Spagnolo S, Spolaore M, Taliercio C, Tinti P, Ugoletti M, Valente M, Zamengo A, Zaniol B, Zaupa M, Cavenago M, Boilson D, Rotti C, Veltri P, Chareyre J, Decamps H, Dremel M, Graceffa J, Geli F, Schunke B, Svensson L, Urbani M, Bonicelli T, Agarici G, Garbuglia A, Masiello A, Paolucci F, Simon M, Bailly-Maitre L, Bragulat E, Gomez G, Gutierrez D, Labate C, Mico G, Moreno JF, Pilard V, Kouzmenko G, Rousseau A, Chakraborty A, Baruah U, Patel H, Singh NP, Patel A, Dhola H, Raval B, Cristofaro S, Fantz U, Heinemann B, Kraus W, Kashiwagi M, Tobari H. First operation in SPIDER and the path to complete MITICA. Rev Sci Instrum 2020; 91:023510. [PMID: 32113382 DOI: 10.1063/1.5133076] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/26/2019] [Accepted: 01/22/2020] [Indexed: 06/10/2023]
Abstract
The requirements of ITER neutral beam injectors (1 MeV, 40 A negative deuterium ion current for 1 h) have never been simultaneously attained; therefore, a dedicated Neutral Beam Test Facility (NBTF) was set up at Consorzio RFX (Padova, Italy). The NBTF includes two experiments: SPIDER (Source for the Production of Ions of Deuterium Extracted from Rf plasma), the full-scale prototype of the source of ITER injectors, with a 100 keV accelerator, to investigate and optimize the properties of the ion source; and MITICA, the full-scale prototype of the entire injector, devoted to the issues related to the accelerator, including voltage holding at low gas pressure. The present paper gives an account of the status of the procurements, of the timeline, and of the voltage holding tests and experiments for MITICA. As for SPIDER, the first year of operation is described, regarding the solution of some issues connected with the radiofrequency power, the source operation, and the characterization of the first negative ion beam.
Collapse
Affiliation(s)
- G Serianni
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - V Toigo
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Bigi
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Boldrin
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - G Chitarin
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - S Dal Bello
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - L Grando
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - A Luchetta
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - D Marcuzzi
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - R Pasqualotto
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - N Pomaro
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - P Zaccaria
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - L Zanotto
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - P Agostinetti
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Agostini
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - V Antoni
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - D Aprile
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Barbisan
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Battistella
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Brombin
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - A Canton
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - R Cavazzana
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Dalla Palma
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Dan
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - R Delogu
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - A De Lorenzi
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M De Muri
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - S Denizeau
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Fadone
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - F Fellin
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - A Ferro
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - E Gaio
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - G Gambetta
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - F Gasparini
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - F Gnesotto
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - P Jain
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - A Maistrello
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - G Manduchi
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - S Manfrin
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - G Marchiori
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - N Marconato
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Moresco
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - T Patton
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Pavei
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - S Peruzzo
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - N Pilan
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - A Pimazzoni
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - R Piovan
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - C Poggi
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Recchia
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - A Rigoni
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - A Rizzolo
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - G Rostagni
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - E Sartori
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Siragusa
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - P Sonato
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - E Spada
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - S Spagnolo
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Spolaore
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - C Taliercio
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - P Tinti
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Ugoletti
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Valente
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - A Zamengo
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - B Zaniol
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Zaupa
- Consorzio RFX (CNR, ENEA, INFN, UNIPD, Acciaierie Venete SpA), Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Cavenago
- INFN-Laboratori Nazionali di Legnaro (LNL), v.le dell'Università 2, I-35020 Legnaro, PD, Italy
| | - D Boilson
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067 St. Paul-lez-Durance, France
| | - C Rotti
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067 St. Paul-lez-Durance, France
| | - P Veltri
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067 St. Paul-lez-Durance, France
| | - J Chareyre
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067 St. Paul-lez-Durance, France
| | - H Decamps
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067 St. Paul-lez-Durance, France
| | - M Dremel
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067 St. Paul-lez-Durance, France
| | - J Graceffa
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067 St. Paul-lez-Durance, France
| | - F Geli
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067 St. Paul-lez-Durance, France
| | - B Schunke
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067 St. Paul-lez-Durance, France
| | - L Svensson
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067 St. Paul-lez-Durance, France
| | - M Urbani
- ITER Organization, Route de Vinon-sur-Verdon, CS 90 046, F-13067 St. Paul-lez-Durance, France
| | - T Bonicelli
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - G Agarici
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - A Garbuglia
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - A Masiello
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - F Paolucci
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - M Simon
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - L Bailly-Maitre
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - E Bragulat
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - G Gomez
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - D Gutierrez
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - C Labate
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - G Mico
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - J F Moreno
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - V Pilard
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - G Kouzmenko
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - A Rousseau
- Fusion for Energy, C/o Josep Pla 2, E-08019 Barcelona, Spain
| | - A Chakraborty
- ITER-India, Institute for Plasma Research, Nr. Indira Bridge, Bhat Village, Gandhinagar, Gujarat 382428, India
| | - U Baruah
- ITER-India, Institute for Plasma Research, Nr. Indira Bridge, Bhat Village, Gandhinagar, Gujarat 382428, India
| | - H Patel
- ITER-India, Institute for Plasma Research, Nr. Indira Bridge, Bhat Village, Gandhinagar, Gujarat 382428, India
| | - N P Singh
- ITER-India, Institute for Plasma Research, Nr. Indira Bridge, Bhat Village, Gandhinagar, Gujarat 382428, India
| | - A Patel
- ITER-India, Institute for Plasma Research, Nr. Indira Bridge, Bhat Village, Gandhinagar, Gujarat 382428, India
| | - H Dhola
- ITER-India, Institute for Plasma Research, Nr. Indira Bridge, Bhat Village, Gandhinagar, Gujarat 382428, India
| | - B Raval
- ITER-India, Institute for Plasma Research, Nr. Indira Bridge, Bhat Village, Gandhinagar, Gujarat 382428, India
| | - S Cristofaro
- IPP, Max-Planck-Institut für Plasmaphysik, Boltzmannstraße 2, D-85748 Garching bei München, Germany
| | - U Fantz
- IPP, Max-Planck-Institut für Plasmaphysik, Boltzmannstraße 2, D-85748 Garching bei München, Germany
| | - B Heinemann
- IPP, Max-Planck-Institut für Plasmaphysik, Boltzmannstraße 2, D-85748 Garching bei München, Germany
| | - W Kraus
- IPP, Max-Planck-Institut für Plasmaphysik, Boltzmannstraße 2, D-85748 Garching bei München, Germany
| | - M Kashiwagi
- National Institutes for Quantum and Radiological Science and Technology, 801-1 Mukoyama, Naka, Ibaraki-ken 311-0193, Japan
| | - H Tobari
- National Institutes for Quantum and Radiological Science and Technology, 801-1 Mukoyama, Naka, Ibaraki-ken 311-0193, Japan
| |
Collapse
|
11
|
Cavenago M, Barbisan M, Delogu R, Pimazzoni A, Poggi C, Ugoletti M, Agostini M, Antoni V, Baltador C, Cervaro V, De Muri M, Giora D, Jain P, Laterza B, Maero G, Maniero M, Martini D, Minarello A, Ravarotto D, Recchia D, Rizzolo A, Romé M, Sartori E, Sattin M, Serianni G, Taccogna F, Valentino V, Variale V, Veltri P. Beam and installation improvements of the NIO1 ion source. Rev Sci Instrum 2020; 91:013316. [PMID: 32012575 DOI: 10.1063/1.5128658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/20/2019] [Accepted: 12/18/2019] [Indexed: 06/10/2023]
Abstract
The NIO1 (Negative Ion Optimization phase 1) source can provide continuous beam operation, which is convenient for systematic parameter and equipment studies. Even in the pure volume production regime, the source yield was found to depend on conditioning procedures. Magnetic configuration tests continued adding magnets to the existing setup; the filter field component Bx has been progressively extended to span the -12 to 5 mT range, and as a trend, source performances improved with |Bx|. The progress of camera beam diagnostics and of the quality of the volume-produced H- beam is also shown. The status, off-line results, and reliability of a first NIO1 cesium oven are discussed; other upgrades in preparation (cavity ring down spectrometer, the end calorimeter, and conceptual tests of the energy recovery system) are also listed.
Collapse
Affiliation(s)
- M Cavenago
- INFN-LNL, v.le dell'Universitá 2, 35020 Legnaro (PD), Italy
| | - M Barbisan
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - R Delogu
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - A Pimazzoni
- INFN-LNL, v.le dell'Universitá 2, 35020 Legnaro (PD), Italy
| | - C Poggi
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - M Ugoletti
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - M Agostini
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - V Antoni
- CNR-Istituto Scienza e Tecnologia dei Plasmi, c. Stati Uniti 4, 35127 Padova, Italy
| | - C Baltador
- INFN-LNL, v.le dell'Universitá 2, 35020 Legnaro (PD), Italy
| | - V Cervaro
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - M De Muri
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - D Giora
- INFN-LNL, v.le dell'Universitá 2, 35020 Legnaro (PD), Italy
| | - P Jain
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - B Laterza
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - G Maero
- Univ. Milano and INFN-MI, v. Celoria 16, 20133 Milano, Italy
| | - M Maniero
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - D Martini
- INFN-LNL, v.le dell'Universitá 2, 35020 Legnaro (PD), Italy
| | - A Minarello
- INFN-LNL, v.le dell'Universitá 2, 35020 Legnaro (PD), Italy
| | - D Ravarotto
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - D Recchia
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - A Rizzolo
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - M Romé
- Univ. Milano and INFN-MI, v. Celoria 16, 20133 Milano, Italy
| | - E Sartori
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - M Sattin
- INFN-LNL, v.le dell'Universitá 2, 35020 Legnaro (PD), Italy
| | - G Serianni
- Consorzio RFX, c. Stati Uniti 4, 35127 Padova, Italy
| | - F Taccogna
- CNR-Istituto Scienza e Tecnologia dei Plasmi, c. Stati Uniti 4, 35127 Padova, Italy
| | | | - V Variale
- INFN-BA, v. Orabona 4, 70126 Bari, Italy
| | - P Veltri
- ITER-Organization, 13067 St. Paul Lez Durance Cedex, France
| |
Collapse
|
12
|
Wimmer C, Bonomo F, Hurlbatt A, Schiesko L, Fantz U, Harder ND, Heinemann B, Mimo A, Orozco G, Agostini M, Barbisan M, Brombin M, Delogu R, Pimazzoni A, Poggi C, Serianni G, Ugoletti M, Veltri P. Beamlet scraping and its influence on the beam divergence at the BATMAN Upgrade test facility. Rev Sci Instrum 2020; 91:013509. [PMID: 32012577 DOI: 10.1063/1.5129336] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/27/2019] [Accepted: 12/12/2019] [Indexed: 06/10/2023]
Abstract
For the ITER fusion experiment, two neutral beam injectors are required for plasma heating and current drive. Each injector supplies a power of about 17 MW, obtained from neutralization of 40 A (46 A), 1 MeV (0.87 MeV) negative deuterium (hydrogen) ions. The full beam is composed of 1280 beamlets, formed in 16 beamlet groups, and strict requirements apply to the beamlet core divergence (<7 mrad). The test facility BATMAN Upgrade uses an ITER-like grid with one beamlet group, which consists of 70 apertures. In a joint campaign performed by IPP and Consorzio RFX to better assess the beam optics, the divergence of a single beamlet was compared to a group of beamlets at BATMAN Upgrade. The single beamlet is measured with a carbon fiber composite tile calorimeter and by beam emission spectroscopy, whereas the divergence of the group of beamlets is measured by beam emission spectroscopy only. When increasing the RF power at low extraction voltages, the divergence of the beamlet and of the group of beamlets is continuously decreasing and no inflection point toward an overperveant beam is found. At the same time, scraping of the extracted ion beam at the second grid (extraction grid) takes place at higher RF power, supported by the absence of the normally seen linear behavior between the measured negative ion density in the plasma close to the extraction system and the measured extracted ion current. Beside its influence on the divergence, beamlet scraping needs to be considered for the determination of the correct perveance and contributes to the measured coextracted electron current.
Collapse
Affiliation(s)
- C Wimmer
- Max-Planck-Institut für Plasmaphysik (IPP), Boltzmannstr. 2, 85748 Garching, Germany
| | - F Bonomo
- Max-Planck-Institut für Plasmaphysik (IPP), Boltzmannstr. 2, 85748 Garching, Germany
| | - A Hurlbatt
- Max-Planck-Institut für Plasmaphysik (IPP), Boltzmannstr. 2, 85748 Garching, Germany
| | - L Schiesko
- Max-Planck-Institut für Plasmaphysik (IPP), Boltzmannstr. 2, 85748 Garching, Germany
| | - U Fantz
- Max-Planck-Institut für Plasmaphysik (IPP), Boltzmannstr. 2, 85748 Garching, Germany
| | - N den Harder
- Max-Planck-Institut für Plasmaphysik (IPP), Boltzmannstr. 2, 85748 Garching, Germany
| | - B Heinemann
- Max-Planck-Institut für Plasmaphysik (IPP), Boltzmannstr. 2, 85748 Garching, Germany
| | - A Mimo
- Max-Planck-Institut für Plasmaphysik (IPP), Boltzmannstr. 2, 85748 Garching, Germany
| | - G Orozco
- Max-Planck-Institut für Plasmaphysik (IPP), Boltzmannstr. 2, 85748 Garching, Germany
| | - M Agostini
- Consorzio RFX, Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Barbisan
- Consorzio RFX, Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Brombin
- Consorzio RFX, Corso Stati Uniti 4, 35127 Padova, Italy
| | - R Delogu
- Consorzio RFX, Corso Stati Uniti 4, 35127 Padova, Italy
| | - A Pimazzoni
- Consorzio RFX, Corso Stati Uniti 4, 35127 Padova, Italy
| | - C Poggi
- Consorzio RFX, Corso Stati Uniti 4, 35127 Padova, Italy
| | - G Serianni
- Consorzio RFX, Corso Stati Uniti 4, 35127 Padova, Italy
| | - M Ugoletti
- Consorzio RFX, Corso Stati Uniti 4, 35127 Padova, Italy
| | - P Veltri
- ITER Organization, Route de Vinon sur Verdon, CS 90 046, 13067 St. Paul-lez-Durance, France
| |
Collapse
|
13
|
Serianni G, Toigo V, Bigi M, Boldrin M, Chitarin G, Dal Bello S, Grando L, Luchetta A, Marcuzzi D, Pasqualotto R, Pomaro N, Zaccaria P, Zanotto L, Agostinetti P, Agostini M, Antoni V, Aprile D, Barbisan M, Battistella M, Brombin M, Cavazzana R, Dalla Palma M, Dan M, De Lorenzi A, Delogu R, De Muri M, Denizeau S, Fadone M, Fellin F, Ferbel L, Ferro A, Gaio E, Gambetta G, Gasparini F, Gnesotto F, Jain P, Maistrello A, Manduchi G, Manfrin S, Marchiori G, Marconato N, Moresco M, Patton T, Pavei M, Peruzzo S, Pilan N, Pimazzoni A, Piovan R, Poggi C, Recchia M, Rizzolo A, Rostagni G, Sartori E, Siragusa M, Sonato P, Spada E, Spagnolo S, Spolaore M, Taliercio C, Tinti P, Ugoletti M, Valente M, Zamengo A, Zaniol B, Zaupa M, Baltador C, Cavenago M, Boilson D, Rotti C, Veltri P, Bonicelli T, Paolucci F, Muriel S, Masiello A, Chakraborty A, Patel H, Singh N, Fantz U, Heinemann B, Kraus W, Kashiwagi M, Tsumori K. SPIDER in the roadmap of the ITER neutral beams. Fusion Engineering and Design 2019. [DOI: 10.1016/j.fusengdes.2019.04.036] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
14
|
Cavenago M, Serianni G, Baltador C, Barbisan M, De Muri M, Pimazzoni A, Poggi C, Veltri P, Aprile D, Antoni V, Armelao L, Baseggio L, Candeloro V, Cervaro V, Franchin L, Jain P, Laterza B, Maniero M, Martini D, Minarello A, Pasqualotto R, Rancan M, Ravarotto D, Recchia M, Sartori E, Sattin M, Ugoletti M, Variale V, Zucchetti S. Experimental experience and improvement of NIO1 H− ion source. Fusion Engineering and Design 2019. [DOI: 10.1016/j.fusengdes.2019.01.071] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
15
|
Conte E, Mushtaq S, Pontone G, Guglielmo M, Baggiano A, Ravagnani P, Trabattoni D, Annoni A, Formenti A, Li Piani L, Poggi C, Montorsi P, Pepi M, Bartorelli AL, Andreini D. P377Plaque volume quantification by coronary computed tomography angiography using intravascular ultrasound as a reference standard a comparison between standard and last generation CT scanners. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez149.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- E Conte
- Cardiology Center Monzino IRCCS, Milan, Italy
| | - S Mushtaq
- Cardiology Center Monzino IRCCS, Milan, Italy
| | - G Pontone
- Cardiology Center Monzino IRCCS, Milan, Italy
| | - M Guglielmo
- Cardiology Center Monzino IRCCS, Milan, Italy
| | - A Baggiano
- Cardiology Center Monzino IRCCS, Milan, Italy
| | - P Ravagnani
- Cardiology Center Monzino IRCCS, Milan, Italy
| | | | - A Annoni
- Cardiology Center Monzino IRCCS, Milan, Italy
| | - A Formenti
- Cardiology Center Monzino IRCCS, Milan, Italy
| | - L Li Piani
- Cardiology Center Monzino IRCCS, Milan, Italy
| | - C Poggi
- Cardiology Center Monzino IRCCS, Milan, Italy
| | - P Montorsi
- Cardiology Center Monzino IRCCS, Milan, Italy
| | - M Pepi
- Cardiology Center Monzino IRCCS, Milan, Italy
| | | | - D Andreini
- Cardiology Center Monzino IRCCS, Milan, Italy
| |
Collapse
|
16
|
Antoni V, Taccogna F, Agostinetti P, Barbisan M, Cavenago M, Chitarin G, Ferron N, Minelli P, Pimazzoni A, Poggi C, Sartori E, Serianni G, Suweis S, Ugoletti M, Veltri P. Negative ion beam source as a complex system: identification of main processes and key interdependence. Rend Fis Acc Lincei 2019. [DOI: 10.1007/s12210-019-00798-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
17
|
Savi D, Mordenti M, Bonci E, Troiani P, Giordani B, D'Alù V, Bertasi S, Cimino G, Rossi P, Poggi C, Palange P, Quattrucci S. Survival After Lung Transplant for Cystic Fibrosis in Italy: A Single Center Experience With 20 Years of Follow-up. Transplant Proc 2018; 50:3732-3738. [PMID: 30577264 DOI: 10.1016/j.transproceed.2018.08.020] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2018] [Accepted: 08/16/2018] [Indexed: 12/18/2022]
Abstract
OBJECTIVES Lung transplantation is currently the only treatment for end-stage respiratory failure in patients with cystic fibrosis (CF). In this study we retrospectively analyzed our experience since the start of the transplantation program in 1996 with focus on survival analysis. METHODS All patients with CF who underwent lung transplant at our center were included (1996-2016). Survival analysis after lung transplant was performed using the Kaplan-Meier estimate, comparing by sex and by 4 eras (1996-2000, 2001-2005, 2006-2010, and 2011-2016). RESULTS In a 20-year period, 243 patients with CF were listed for lung transplant; 123 patients (61 male, 62 female) underwent transplant, and 85 died while waiting for donor organs. The mean (SD) and median age at transplant was 27.7 (8.7) years and 26.9 years (range, 9.1 - 52.1 years), respectively. Mean (SD) forced expiratory volume in the first second was 27.6 (9.7)% predicted; 115 patients (92.0%) were pancreatic insufficient, and 43 patients (34.0%) had CF-related diabetes. Removing patients with CF who died within the first 3 postoperative months, the mean (SD) and median survival after transplant were 8.2 (5.7) years and 7.5 years (range, 3 months-20 years), respectively. Overall post-lung transplant 1-year survival was 93.6%, 5-year survival was 71.4%, 10-year survival was 53.6%, 15-year survival was 36.7%, and 20-year survival was 31.6%. We found no difference in survival between sex (P = .22) and among the 4 eras (P = .56). CONCLUSIONS Survival after lung transplant in our single center is similar to international data.
Collapse
Affiliation(s)
- D Savi
- Department of Public Health and Infectious Diseases, Adult Cystic Fibrosis Center, Sapienza University of Rome, Italy; Cystic Fibrosis Unit, Bambino Gesù Children's Hospital, Rome, Italy.
| | - M Mordenti
- Department of Public Health and Infectious Diseases, Adult Cystic Fibrosis Center, Sapienza University of Rome, Italy
| | - E Bonci
- Department of Experimental Medicine, Sapienza University of Rome, Italy
| | - P Troiani
- Department of Pediatrics, Cystic Fibrosis Center, Sapienza University of Rome, Italy
| | - B Giordani
- Lega Italiana Fibrosi Cistica ONLUS-LIFC, Rome, Italy
| | - V D'Alù
- Department of Public Health and Infectious Diseases, Adult Cystic Fibrosis Center, Sapienza University of Rome, Italy
| | - S Bertasi
- Department of Pediatrics, Cystic Fibrosis Center, Sapienza University of Rome, Italy
| | - G Cimino
- Department of Public Health and Infectious Diseases, Adult Cystic Fibrosis Center, Sapienza University of Rome, Italy
| | - P Rossi
- Department of Pediatrics, Cystic Fibrosis Center, Sapienza University of Rome, Italy
| | - C Poggi
- Department of General Surgery and Organ Transplant, Division of Thoracic Surgery, Sapienza University of Rome, Italy
| | - P Palange
- Department of Public Health and Infectious Diseases, Adult Cystic Fibrosis Center, Sapienza University of Rome, Italy
| | - S Quattrucci
- Department of Pediatrics, Cystic Fibrosis Center, Sapienza University of Rome, Italy
| |
Collapse
|
18
|
Carillo C, Pecoraro Y, Anile M, Poggi C, Oliva A, Amore D, Bruschini P, Naldi G, Mantovani S, Francioni F, Pugliese F, De Giacomo T, Venuta F, Diso D. Colistin-based Treatment of Multidrug-resistant Gram-negative Bacterial Pulmonary Infections After Lung Transplantation. Transplant Proc 2018; 51:202-205. [PMID: 30661895 DOI: 10.1016/j.transproceed.2018.04.068] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2018] [Accepted: 04/13/2018] [Indexed: 01/06/2023]
Abstract
BACKGROUND Lung transplantation (LT) is a viable option for a select group of patients with end-stage lung disease. However, infections are a major complication after LT, accounting for significant morbidity and mortality. Several germs may be responsible; multidrug-resistant Gram-negative (MDR-GN) bacteria are emerging. Colistin is widely used in the treatment of these infections and is administered by inhalation and/or parenterally. At our institution, in patients with tracheostomy, colistin is administered by direct instillation in the airway during bronchoscopy. We reviewed a series of patients who underwent LT complicated by postoperative MDR-GN bacterial pulmonary infection. METHODS From January 2015 to May 2017, 26 lung transplants were performed. In the postoperative course, 14 (54%) developed MDR-GN bacterial infection; respiratory specimen culture, blood tests, and chest X-ray were considered. Colistin was the only antibiotic usable. Thirteen patients received intravenous (IV) colistin; in the subgroup of patients with tracheostomy, colistin was instilled directly in the airway, and 6 patients received inhaled colistin. RESULTS Seven patients needed tracheostomy. Pseudomonas aeruginosa was the predominant infection (86%), with Acinetobacter baumanii seen in 2 cases (14%). An early clinical-laboratory response was observed in 9 patients (64%). White blood cell count and C-reactive protein values improved (P = .02 and P = .001, respectively). A significant reduction in bacterial load was observed on microbiologic bronchoalveolar lavage specimens. CONCLUSION Colistin instilled directly in the airway did not show side effects. The combination of IV and inhaled/instilled colistin could be a useful treatment option for MDR-GN infections after LT.
Collapse
Affiliation(s)
- C Carillo
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
| | - Y Pecoraro
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - M Anile
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - C Poggi
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - A Oliva
- Department of Public Health and Infectious Disease, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - D Amore
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - P Bruschini
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - G Naldi
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - S Mantovani
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - F Francioni
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - F Pugliese
- Division of Anesthesia and Transplant Intensive Care Unit, Department of General Surgery and Organ Transplant, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - T De Giacomo
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - F Venuta
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - D Diso
- Division of Thoracic Surgery, Department of General Surgery and Organ Transplant "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| |
Collapse
|
19
|
Fiorelli A, D’Andrilli A, Anile M, Cascone R, Occhiati L, Diso D, Cassiano F, Poggi C, Ibrahim M, Cusumano G, Terminella A, Failla G, La Sala A, Bezzi M, Innocenti M, Torricelli E, Venuta F, Rendina EA, Santini M, Andreetti C. F-075THE COST/BENEFIT OF UNIDIRECTIONAL ENDOBRONCHIAL VALVES IMPLANT FOR MANAGEMENT OF PERSISTENT AIR-LEAKS: RESULTS OF A MULTICENTRE STUDY. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
20
|
Affiliation(s)
- A. R. Liboff
- Department of Physics, Oakland University, Rochester Hills, MI, USA
| | - C. Poggi
- Studio Ingegneria Claudio Poggi, Genoa, Italy
| | - P. Pratesi
- Studio Ingegneria Claudio Poggi, Genoa, Italy
| |
Collapse
|
21
|
D'Andrilli A, Andreetti C, Ciccone A, Maurizi G, Ibrahim M, Poggi C, Menna C, Vanni C, Venuta F, Rendina E. V-009SUCCESSFUL ENDOSCOPIC TREATMENT OF SEVERE ISCHAEMIC DAMAGE OF THE BRONCHUS AFTER BILOBECTOMY. Interact Cardiovasc Thorac Surg 2016. [DOI: 10.1093/icvts/ivw260.09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
22
|
Delogu RS, Poggi C, Pimazzoni A, Rossi G, Serianni G. Analysis of diagnostic calorimeter data by the transfer function technique. Rev Sci Instrum 2016; 87:02B932. [PMID: 26932104 DOI: 10.1063/1.4936081] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
This paper describes the analysis procedure applied to the thermal measurements on the rear side of a carbon fibre composite calorimeter with the purpose of reconstructing the energy flux due to an ion beam colliding on the front side. The method is based on the transfer function technique and allows a fast analysis by means of the fast Fourier transform algorithm. Its efficacy has been tested both on simulated and measured temperature profiles: in all cases, the energy flux features are well reproduced and beamlets are well resolved. Limits and restrictions of the method are also discussed, providing strategies to handle issues related to signal noise and digital processing.
Collapse
Affiliation(s)
- R S Delogu
- Consorzio RFX, Corso Stati Uniti, 35127 Padova, Italy
| | - C Poggi
- Università degli Studi di Padova, Via 8 Febbraio 1848, 35122 Padova, Italy
| | - A Pimazzoni
- Consorzio RFX, Corso Stati Uniti, 35127 Padova, Italy
| | - G Rossi
- Università degli Studi di Padova, Via 8 Febbraio 1848, 35122 Padova, Italy
| | - G Serianni
- Consorzio RFX, Corso Stati Uniti, 35127 Padova, Italy
| |
Collapse
|
23
|
Fiorelli A, D'Andrilli A, Poggi C, Diso D, Anile M, Polverino M, Failla G, Venuta F, Rendina E, Santini M. O-018SEQUENTIAL BILATERAL BRONCHOSCOPIC LUNG VOLUME REDUCTION WITH ONE-WAY VALVES FOR HETEROGENEOUS EMPHYSEMA. Interact Cardiovasc Thorac Surg 2015. [DOI: 10.1093/icvts/ivv204.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
Menna C, Andreetti C, Ibrahim M, D'Andrilli A, Ciccone AM, Maurizi G, Poggi C, Rendina EA. 213 * POST-THORACOTOMY PAIN: VIDEOTHORACOSCOPIC VERSUS MINITHORACOTOMY APPROACH. Interact Cardiovasc Thorac Surg 2013. [DOI: 10.1093/icvts/ivt372.213] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
25
|
Cusumano G, Margaritora S, Lococo F, Siciliani A, Maurizi G, Poggi C, Marra A, Hillejan L, Rendina A, Granone P. P-129SLEEVE LOBECTOMY VERSUS PNEUMONECTOMY AFTER INDUCTION THERAPY: SHORT AND LONG-TERM RESULTS OF A MULTICENTRIC STUDY. Interact Cardiovasc Thorac Surg 2013. [DOI: 10.1093/icvts/ivt288.129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
26
|
Carlesimo M, Abruzzese C, Cortesi G, Ciccone A, Poggi C, Lombardi M, Moscetti A, La Verde G, Mari E. Pseudoxanthoma Elasticum and Light-Chain Amyloidosis. EUR J INFLAMM 2012. [DOI: 10.1177/1721727x1201000329] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Pseudoxanthoma elasticum is a heritable disorder of connective tissue characterized by cutaneous, vascular and ocular changes that result from the accumulation of fragmented elastic fibres. Even though the etiopathogenesis is not still completely understood, in recent years in literature some Authors have considered pseudoxanthoma elasticum as a metabolic disorder. We present the case of a 45-year-old man affected by pseudoxanthoma elasticum and light-chain amyloidosis and we discuss the possible reasons that led to this association.
Collapse
Affiliation(s)
- M. Carlesimo
- NESMOS, U.O.C. Dermatology, Sant'Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - C. Abruzzese
- NESMOS, U.O.C. Dermatology, Sant'Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - G. Cortesi
- NESMOS, U.O.C. Dermatology, Sant'Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - A.M. Ciccone
- U.O.C. Thorax Surgery, Sant'Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - C. Poggi
- U.O.C. Thorax Surgery, Sant'Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - M. Lombardi
- U.O.C. Histopathology, Sant Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psychology, Rome, Italy
| | - A. Moscetti
- U.O.C. Ematology Sant Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psycology, Rome, Italy
| | - G. La Verde
- U.O.C. Ematology Sant Andrea Hospital University of Rome “Sapienza”, Faculty of Medicine and Psycology, Rome, Italy
| | - E. Mari
- U.O.C. Clinica Dermatologica Dipartimento di Medicina Interna e Specialita Mediche University of Rome “Sapienza”, Rome, Italy
| |
Collapse
|
27
|
Filippi L, Serafini L, Gozzini E, Poggi C, Moroni M, Fiorini P. Persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide and prostacyclin, responsive to neuromuscular blockade. Minerva Pediatr 2011; 63:233-235. [PMID: 21654603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Neonatal pulmonary hypertension refractory to high frequency ventilation (HFOV) and inhaled nitric oxide (iNO) is an occasional occurrence. We report a full-term neonate with severe pulmonary hypertension unresponsive to the treatment with HFOV and iNO, later associated with prostacyclin, who rapidly improved after the addition of vecuronium, a neuromuscular blocker.
Collapse
Affiliation(s)
- L Filippi
- Neonatal Intensive Care Unit, Department of Perinatal Medicine, A. Meyer University Children's Hospital, Florence, Italy.
| | | | | | | | | | | |
Collapse
|
28
|
Andreetti C, Ibrahim M, Ciccone A, D'Andrilli A, Poggi C, Maurizi G, Pavan A, Rendina EA. Autologus platelet gel for the management of persistent alveolar fistula after lung resection. MINERVA CHIR 2010; 65:695-699. [PMID: 21224802] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Postoperative alveolar fistula (AF) associated with pleural cavity (PC) is a serious complication and a therapeutic challenge in thoracic surgery. The purpose of this study was to assess the efficacy of the use of the autologous platelet gel for the treatment of AF and PC. We treated a patient with post lung resection persistent alveolar fistula using a autologous platelet gel, a cellular compose produces at the Division of Immunohaematoligy and Trasfusion. The platelet gel-PRP (Platelet-Rich Plasma) is a biological material made of autologous platelets, extracted from a small amount of the patient's blood, centrifuged at 1100 g for 9 min. The PRP obtained was activated by addition of autologous thrombin and calcium chloride to form a matrix of fibrin (PRFM) thick. The patient presented important air leak after middle lobe wedge resection for solitary lung lesion with standard open decortication for important pleural adhesions post pleuritis. On postoperative day XIII the patient developed a thoracic empyema and consequently underwent a antibiotic pleural irrigation through the chest drainage based on the microbiological analysis of the pleural fluid. After a week we obtained the resolution of the empyema but a residual space remained and air leak persisted. We treated the patient with autologous platelet gel. We administer 7.5 mL of the autologous platelet gel across the chest drainage ever 72 hours for 3 times. After the third application we had the closure of the cavity and the cessation of air leak. Autologous platelet gel is easy to use, safe and inexpensive. It can be considered a valid therapeutic option in selected patients with a alveolar fistula and a lung partial re-expansion. The product consist of a significant amount of cellular components with healing anti-inflammatory an proregenerative properities that permit the body to heal tissue wounds faster and more efficiently. A sterile pleural cavity is fundamental conditions for the final success of the procedure.
Collapse
Affiliation(s)
- C Andreetti
- Department of Thoracic Surgery, La Sapienza, University of Rome, Sant'Andrea Hospital, Rome, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
29
|
D'Andrilli A, Maurizi G, Poggi C, Ciccone AM, Ibrahim M, Andreetti C, Natili M, Rendina EA. [T4 lung cancer: results of surgical treatment]. MINERVA CHIR 2010; 65:569-575. [PMID: 21081868] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/30/2023]
Abstract
Stage T4 non small cell lung cancer (NSCLC) includes an heterogeneous group of locally advanced tumors. Results of surgery alone and of chemo and/or radiotherapy are disappointing with 5-year survival rates under 10%. Although palliative chemo-radiotherapy is the treatment of choice in most cases, radical resection has shown prognostic benefit in selected groups of patients with tumor infiltrating Superior Vena Cava, carina, aorta, left atrium and vertebral bodies. Completeness of resection and absence of mediastinal nodal involvement are fundamental conditions for the long-term success of surgery. Increased postoperative 30-day mortality and 90-day mortality rates have been reported up to 8% and 18% respectively. Neoadjuvant therapy, in the last decades, has shown to improve survival of T4 NSCLC patients undergoing surgery and to increase the number of patients suitable for surgical resection. Surgical resection is not indicated in patients with neoplastic pleural effusion since it is generally related to a worse prognosis in such cases. Conversely, patients with T4 tumor due to neoplastic satellite nodule in the same lobe are good surgical candidates. In some studies, these patients show a significant survival advantage after surgical treatment with respect to patients with other types of T4 tumors, when no mediastinal nodal involvement is associated.
Collapse
Affiliation(s)
- A D'Andrilli
- Divisione di Chirurgia Toracica, Università di Roma "La Sapienza", Ospedale Sant'Andrea, Roma, Italia
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Bartolini L, De Dominicis L, Fornetti G, Francucci M, Guarneri M, Poggi C, Ricci R. Improvement in underwater phase measurement of an amplitude-modulated laser beam by polarimetric techniques. Opt Lett 2007; 32:1402-4. [PMID: 17546135 DOI: 10.1364/ol.32.001402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
The phase of the amplitude-modulated radiation reflected by a Lambertian target immersed in water was measured by using a linearly and circularly polarized sounding laser beam. Different values of the water extinction coefficient in the range of 0.06 - 2 m(-1) were realized by adding skim milk as a scattering element. It is shown that very efficient rejection of optical noise, resulting in reliable phase measurements, is accomplished with a cross-polarized and copolarized detection scheme for linear and circular polarization, respectively. The experiment demonstrates that phase measurements are very sensitive to optical noise suppression and that, as far as single scattering is the main involved mechanism, significant improvements can be achieved by adopting a polarization control on both the transmitter and the receiver stages of the apparatus.
Collapse
Affiliation(s)
- L Bartolini
- Italian National Agency for New Technologies, Energy and the Environment, Frascati, Italy
| | | | | | | | | | | | | |
Collapse
|
31
|
Lafeuillade A, Poggi C, Hittinger G, Counillon E, Emilie D. Predictors of Plasma Human Immunodeficiency Virus Type 1 RNA Control after Discontinuation of Highly Active Antiretroviral Therapy Initiated at Acute Infection Combined with Structured Treatment Interruptions and Immune‐Based Therapies. J Infect Dis 2003; 188:1426-32. [PMID: 14624367 DOI: 10.1086/379251] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2003] [Accepted: 06/17/2003] [Indexed: 11/04/2022] Open
Abstract
Thirty patients with acute human immunodeficiency virus (HIV) type 1 infection received a combination of 3 antiretroviral drugs (n=15) or 4 antiretroviral drugs plus hydroxyurea and interleukin-2 (n=15) for 24 months, followed by 1-3 structured therapeutic interruptions (STIs). Viral control, defined as maintaining plasma viremia <5000 copies/mL without therapy, was achieved in 14 cases. Lymphocyte subsets, plasma HIV-1 RNA loads, proviral DNA loads in peripheral blood mononuclear cells (PBMCs), residual HIV-1 RNA loads in PBMCs and in lymph node cells, and anti-p24 lymphoproliferative response were measured. In the multivariate analysis, proviral DNA loads in PBMCs and anti-p24 lymphoproliferative response assessed at 24 months were independently correlated with viral control after STI. These results enabled us to define a subgroup of patients for whom safe discontinuation of therapy initiated at acute infection was suitable and contributed to ascertaining priority for biological parameter assessment in future clinical trials.
Collapse
Affiliation(s)
- A Lafeuillade
- Department of Infectious Diseases, Chalucet Hospital, Toulon, France.
| | | | | | | | | |
Collapse
|
32
|
Lafeuillade A, Solas C, Chadapaud S, Hittinger G, Poggi C, Lacarelle B. HIV-1 RNA levels, resistance, and drug diffusion in semen versus blood in patients receiving a lopinavir-containing regimen. J Acquir Immune Defic Syndr 2003; 32:462-4. [PMID: 12640207 DOI: 10.1097/00126334-200304010-00018] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Lafeuillade A, Poggi C, Chadapaud S, Hittinger G, Chouraqui M, Delbeke E. HIV-1 induction-maintenance at the lymph node level: the "Apollo-97" Study. J Acquir Immune Defic Syndr 2001; 28:154-7. [PMID: 11588509 DOI: 10.1097/00042560-200110010-00007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVE To assess the effects of five-drug combination therapy on HIV-1 load in lymph nodes and subsequent maintenance with four and three drugs. METHODS Ten pharmacotherapeutically naive patients received a combination of zidovudine, lamivudine, didanosine, ritonavir, and saquinavir for 24 weeks, then zidovudine, lamivudine, didanosine, and saquinavir for the next 24 weeks, and finally zidovudine, lamivudine, and saquinavir for the last 24 weeks. HIV-1 RNA in lymph nodes was measured using quantitative polymerase chain reaction (PCR) at baseline, after 12, 24, 48, and 78 weeks. Plasma HIV-1 RNA, proviral DNA in peripheral blood mononuclear cells (PBMCs), circulating lymphocyte subsets, and protease inhibitor levels in blood were also regularly measured. Genotypic resistance was assessed in the different compartments in 2 patients who were failed by therapy. RESULTS HIV-1 RNA decreased in lymph nodes in 9 patients and was stable in 1 despite initial control of plasma replication <20 copies/ml in each patient. Lymph node levels rebounded in 1 patient at week 72 as a result of lack of adherence and remained stable in the 8 others despite maintenance regimens. This represents a mean drop of -3.17 log in lymph nodes for the 8 patients maintaining undetectable viremia at 72 weeks. In the patient with stable lymph node viral RNA, selection of the M184V mutation was demonstrated at this level before detection in plasma and low blood saquinavir levels were found throughout the study. Continuous improvements in immune parameters were observed in all cases, although PBMC proviral DNA levels either showed a continuous decrease or stabilized to a plateau. CONCLUSIONS More complex regimens do not perform better in lymph nodes than classic triple therapy. The persistence of HIV-1 RNA in lymph nodes could be related with cellular resistance mechanisms rather than an insufficient potency of the regimens.
Collapse
Affiliation(s)
- A Lafeuillade
- Department of Infectious Diseases, Laboratory of Virology, General Hospital, Toulon, France.
| | | | | | | | | | | |
Collapse
|
34
|
Abstract
OBJECTIVE To assess phenotypic and genotypic cross-resistance to nucleoside reverse transcriptase inhibitors in patients treated with a combination including zidovudine, who were switched to a combination including stavudine. METHODS We analysed 24 clinical HIV-1 isolates from 12 patients before and several months after therapeutic switching. Plasma HIV-1 RNA was measured using quantitative polymerase chain reaction (Roche). Genotypic resistance was measured by sequencing the reverse transcriptase gene from plasma HIV-1 RNA. Phenotypic resistance was measured using a recombinant assay (Virco). RESULTS Patients were treated with a combination including zidovudine for a mean (+/- SEM) period of 21.8 +/- 3.5 months and had a plasma viral load of 4.1 +/- 0.2 log HIV-1 RNA copies/mL (time 1). After a mean period of 19.3 +/- 1.6 months following the therapeutic change, the plasma viral load was 3.6 +/- 0.1 log copies/mL (time 2). At time 1, genotypic resistance to zidovudine was found in all cases (41L: four cases; 41L, 215Y: five cases; 41L, 210W, 215Y: two cases; K70R: one case) with a mean 6.6 +/- 1.6-fold increase in the median inhibitory concentration (IC50) to zidovudine and 1.7 +/- 0.4-fold to stavudine. At time 2, genotypic resistance to zidovudine was found in 11 out of 12 cases (41L: two cases; 41L, 215Y: six cases; 41L, 210W, 215Y: two cases; M41L, D67N, L210W, T215Y: one case) with a mean 18.9 +/- 8.8-fold increase in the IC50 to zidovudine and 1.4 +/- 0.4-fold to stavudine CONCLUSIONS In this clinical series of patients with suboptimal control of plasma HIV-1 RNA using a combination including zidovudine, the presence of zidovudine-related mutations was associated with a decreased phenotypic sensitivity to this drug. Despite persistent HIV-1 replication, switching to stavudine was associated with a further decrease in phenotypic sensitivity to zidovudine but not to stavudine after 19 months. These data suggest that stavudine remains a possible option in zidovudine-experienced patients.
Collapse
Affiliation(s)
- A Lafeuillade
- Department of Infectious Diseases and Laboratory of Virology, General Hospital, Toulon, France.
| | | | | | | |
Collapse
|
35
|
Lafeuillade A, Halfon P, Chadapaud S, Hittinger G, Khiri H, Poggi C. Potential adverse effects of structured therapeutic interruptions on the pool of HIV-infected cells. J Acquir Immune Defic Syndr 2001; 28:197-8. [PMID: 11588517 DOI: 10.1097/00042560-200110010-00015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
36
|
Lafeuillade A, Poggi C, Chadapaud S, Hittinger G, Khiri H, Halfon P. Impact of immune interventions on proviral HIV-1 DNA decay in patients receiving highly active antiretroviral therapy. HIV Med 2001; 2:189-94. [PMID: 11737400 DOI: 10.1046/j.1468-1293.2001.00065.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
OBJECTIVE To measure the evolution of proviral HIV-1 DNA levels in patients receiving highly active antiretroviral therapy (HAART) compared to those treated with HAART plus interleukin-2 (IL-2) and hydroxyurea. DESIGN Prospective randomised trial. METHODS Twenty-two HIV-1 infected patients were randomly assigned to a five-drug antiretroviral regimen for 72 weeks, with or without IL-2, followed by a three-drug regimen up to week 120 with additional hydroxyurea in patients having received IL-2. HIV-1 DNA levels in peripheral blood mononuclear cells (PBMC) were measured regularly using the Amplicor Monitor kit from Roche Diagnostics (Meylan, France). Potentially infectious HIV-1 was cultured in enhanced conditions from circulating CD4 T cells at week 120. RESULTS During the study period of 120 weeks, HIV-1 DNA levels in PBMC decreased by -1.1 log in patients treated with HAART only compared with -1.8 log in patients with additional IL-2 and hydroxyurea. A two-phase decay rate was observed, with an inflexion point at 12 weeks. The second decay was slow, with mean half-lives of 130.1 +/- 21.3 weeks and 95.1 +/- 26.3 weeks for patients on HAART and those receiving additional IL-2 and hydroxyurea, respectively. At week 120, one out of 11 patients with HAART alone compared to six out of 11 in the group with IL-2 and hydroxyurea had undetectable proviral DNA levels and three of them had unsuccessful recovery of replication-competent HIV-1 from blood CD4 T cells. CONCLUSION Therapeutic strategies combining HAART and immune interventions have higher potency to decrease the number of infected cells than HAART alone.
Collapse
Affiliation(s)
- A Lafeuillade
- Department of Infectious Diseases, and Laboratory of Virology, General Hospital, Toulon and Laboratory Alphabio, Marseilles, France.
| | | | | | | | | | | |
Collapse
|
37
|
Moreau X, Poggi C, Chollet L, Pradie MP, Profizi N. [Eradication of hepatitis C virus after 3 months of interferon alpha treatment in a patient with chronic C hepatitis. A new case]. Gastroenterol Clin Biol 2001; 25:715-6. [PMID: 11673740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
|
38
|
Mogentale-Profizi N, Chollet L, Stévanovitch A, Dubut V, Poggi C, Pradié MP, Spadoni JL, Gilles A, Béraud-Colomb E. Mitochondrial DNA sequence diversity in two groups of Italian Veneto speakers from Veneto. Ann Hum Genet 2001; 65:153-66. [PMID: 11427175 DOI: 10.1017/s0003480001008545] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2000] [Indexed: 11/06/2022]
Abstract
Although frequencies of mitochondrial DNA (mtDNA) haplogroups in the different European populations are rather homogenous, there are a few European populations or linguistic isolates that show different mtDNA haplogroup distributions; examples are the Saami and Ladin speakers from the eastern Italian Alps. MtDNA sequence diversity was analysed from subjects from two villages in Veneto. The first, Posina, is situated in the Venetian Alps near Vicenza. The second, Barco di Pravisdomini is a village on the plains near Venice. In spite of their common Veneto dialect, the two group populations have not preserved a genetic homogeneity; particularly, they show differences in T and J haplogroups frequencies. MtDNA diversity in these two groups seems to depend more on their geographic situation.
Collapse
Affiliation(s)
- N Mogentale-Profizi
- Département de Biologie Moléculaire, Centre Hospitalier de Toulon-La Seyne, Toulon Cedex, France
| | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Lafeuillade A, Poggi C, Chadapaud S, Hittinger G, Chouraqui M, Pisapia M, Delbeke E. Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission. J Acquir Immune Defic Syndr 2001; 26:44-55. [PMID: 11176268 DOI: 10.1097/00126334-200101010-00006] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
A pilot study of a combination of highly active antiretroviral therapy (HAART) and cytokines in early HIV-1 infection has been undertaken to test the hypothesis that HIV-1 remission can be reached with this strategy by flushing latently infected viral reservoirs. Ten previously antiretroviral naive patients have received a combination of zidovudine, lamivudine, didanosine, saquinavir, and ritonavir for 72 weeks. Between weeks 12 and 48, three courses of interleukin (IL)-2 (7.5 millions of international units [MUI] twice a day for 5 consecutive days) and 2 courses of gamma-interferon (IFN) (100 microg every other day during 2 weeks) were administered subcutaneously. All patients reached plasma HIV-1 RNA levels < 20 copies/ml within 12 +/- 4 weeks. Transient increases in plasma levels (< 120 copies/ml) were observed during administration of IL-2, but less frequently during gamma-IFN administration. HIV-1 RNA decreased in lymph node cells by approximately 4 log, then remained stable after week 24. A mean drop of -0.8 log in peripheral blood mononuclear cell (PBMC) proviral DNA was observed during the trial. Isolation of potentially infectious HIV-1 was successful in each case by coculture of CD4+ T cells taken at week 72. The 2 patients who stopped therapy at the end of the trial showed rebounding plasma HIV-1 RNA levels within a few weeks. No additional mutations were selected in comparison with those present at baseline in 8 patients. In addition, 2 patients developed new mutations in the reverse transcriptase or protease gene and in 1 case, resistance selection was found in lymphoid tissue HIV-1 RNA but not in latently infected cells. In all cases, a rapid increase in both naive and memory CD4+ T cells was observed, with a reduction in activation markers and preservation of the CD8+CD28+ subset. Consequently, an aggressive regimen of HAART and cytokines administered in early stage disease is associated with a positive effect in terms of proviral load reduction and immune reconstitution but is unable to induce HIV-1 remission, allowing low levels of viral replication to persist in lymphoid reservoirs.
Collapse
Affiliation(s)
- A Lafeuillade
- Department of Infectious Diseases, Laboratory of Virology, and Immunology Laboratory; General Hospital, Toulon, France.
| | | | | | | | | | | | | |
Collapse
|
40
|
Poggi C, Profizi N, Djediouane A, Chollet L, Hittinger G, Lafeuillade A. Long-term evaluation of triple nucleoside therapy administered from primary HIV-1 infection. AIDS 1999; 13:1213-20. [PMID: 10416525 DOI: 10.1097/00002030-199907090-00010] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE To study the long-term effect of triple-drug therapy initiated at the time of primary HIV-1 Infection and to evaluate the persistance of replication-competent virus in responding patients. METHODS Prospective open-label pilot study. Patients received a combination of zidovudine, didanosine and lamivudine. Viral sequencing of the reverse transcriptase gene was performed before therapy and during follow-up. HIV-1 RNA and DNA as well as CD4 and CD8 T lymphocyte subsets were measured in blood and in lymph node biopsies during therapy. Isolated blood CD4 T cells were cultured in conditions that improved HIV isolation. Three patients received in vivo interleukin-2 and gamma-interferon in order to try to identify intracellular pools of replication-competent virus. SETTING A tertiary care general hospital. PATIENTS Fifteen patients observed within 28 days following the acute retroviral syndrome. RESULTS After a mean follow-up of 27.5+/-2.9 months, plasma RNA remained < 20 copies/ml (four patients), fluctuated between 20 and 120 copies/ml (six patients) or rebounded (five patients). M184V and/or T215Y mutations were demonstrated in two of these last five patients. Proviral DNA in peripheral blood mononuclear cells (PBMC) decreased by an average of -1 log after 16+/-3 months, reaching undetectable levels in three patients. The culture of isolated CD4 T cells yielded virus in all but two patients. These last were characterized by a waning antibody reactivity on the Western blot, undetectable proviral DNA in PBMC and undetectable RNA in lymph nodes. Cytokine administration in vivo had no effect in one patient and unmasked plasma RNA in the other. Stopping therapy in the first patient led to a rebound in plasma RNA. CONCLUSION Despite a lack of detectable plasma viral activity in some patients after 3 years of triple nucleoside therapy administered since the acute retroviral syndrome, replication-competent virus can still be demonstrated.
Collapse
Affiliation(s)
- C Poggi
- Laboratory of Biology, General Hospital, Toulon, France
| | | | | | | | | | | |
Collapse
|
41
|
Hittinger G, Poggi C, Delbeke E, Profizi N, Lafeuillade A. Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients. Infection 1998; 26:100-3. [PMID: 9561379 DOI: 10.1007/bf02767768] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The plasma levels of HIV-1 RNA, tumor necrosis factor alpha (TNF-alpha), soluble receptors type II of TNF-alpha (sTNF-alpha RII), soluble receptors of interleukin-4 (sR IL-4), interleukin-6 (IL-6), soluble receptors of interleukin-6 (sR IL-6), granulocyte macrophage colony stimulating factor (GM-CSF), soluble receptors of GM-CSF (sR GM-CSF), RANTES, MIP-1 alpha and MIP-1 beta were measured in 80 HIV-infected patients. All patients had not been treated previously with antiretroviral drugs and did not present a recent history of opportunistic infection. A statistically significant correlation was found between HIV-1 RNA and TNF-alpha (p = 0.005) or sTNF-alpha RII levels (p < 0.001). RANTES and MIP-1 alpha levels did not correlate with HIV-1 RNA. MIP-1 beta levels were correlated with plasma RNA titers in patients with CD4+ T cells < 200 x 10(6)/l (p = 0.03). MIP-1 alpha and sR IL-4 levels were significantly different according to the CD4+ T cell range (p = 0.003 and p = 0.0002, respectively). GM-CSF and sR GM-CSF were undetectable in each case. These data confirm that HIV-1 replication in the plasma is correlated with TNF-alpha levels, but do not show a clear correlation with levels of the chemokines studied.
Collapse
Affiliation(s)
- G Hittinger
- Dept. of Infectious Diseases, Hôpital Chalucet, Toulon, France
| | | | | | | | | |
Collapse
|
42
|
Lafeuillade A, Chollet L, Hittinger G, Profizi N, Costes O, Poggi C. Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of <200 copies/mL. J Infect Dis 1998; 177:235-8. [PMID: 9419197 DOI: 10.1086/517362] [Citation(s) in RCA: 57] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Human immunodeficiency virus type 1 (HIV-1) RNA was measured in lymph node (LN) mononuclear cells of 50 patients with sustained plasma RNA of <200 copies/mL with therapy. Six patients had received a combination of three reverse transcriptase inhibitors (RTIs) since primary infection, 11 received this same combination during chronic disease, 21 received a combination of two RTIs plus a protease inhibitor (PI), and 12 received three RTIs plus a PI. The mean overall duration of therapy was 8.9 +/- 0.5 months (range, 5-24), with no significant difference between groups. LN HIV-1 RNA levels varied from undetectable to 1.7 million copies/10(6) cells according to cases. The mean LN HIV-1 RNA level was 2.99 +/- 0.42 log10 copies/10(6) cells in the 17 patients receiving three RTIs compared with 1.93 +/- 0.25 log10 copies/10(6) cells in the 33 patients receiving a PI (t test, P = .02). These data demonstrate that highly active antiretroviral regimens have unequivalent effects on LNs and invite redefinition of suboptimal therapy at this level.
Collapse
Affiliation(s)
- A Lafeuillade
- Department of Infectious Diseases, General Hospital, Toulon, France.
| | | | | | | | | | | |
Collapse
|
43
|
Lafeuillade A, Poggi C, Djediouane A, Chollet L, Profizi N, Sayada C. A pilot study of a combination of three reverse transcriptase inhibitors in HIV-1 infection. Antivir Ther 1997; 2:219-27. [PMID: 11327441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
The objective of this study was to evaluate the efficacy and tolerability of a combination of three reverse transcriptase inhibitors in patients with human immunodeficiency virus type 1 (HIV-1) infection. The investigation was an open pilot study of 48 weeks duration. Forty-five patients with CD4 cell counts between 50 and 500 cells/mm3 received a combination of oral zidovudine (200 mg three times daily) plus didanosine (200 mg twice daily) and lamivudine (150 mg twice daily). Plasma HIV-1 RNA and CD4 cell levels were measured weekly during the first month, at weeks 6, 8 and monthly thereafter. HIV-1 RNA levels were also measured sequentially in the lymph nodes of five patients after the initiation of therapy, and after several months of undetectable plasma RNA in 10 additional cases. Sequencing was performed on virus from the peripheral blood mononuclear cells of a subset of 14 patients after a mean period of 11+/-1 months on therapy. The mean (+/-SE) plasma viral load was 5.04+/-0.09 log10 copies/ml and the mean CD4 cell count was 339+/-14 cells/mm3 at baseline. Plasma HIV-1 RNA levels decreased exponentially in each case and became undetectable in 36 out of 42 cases who continued therapy for 24 weeks. HIV-1 RNA levels were < 20 copies/ml in 73% of these cases with undetectable HIV RNA. HIV-1 RNA decreased exponentially in lymph nodes after the initiation of therapy. The mean residual lymph node HIV-1 RNA level was 3.06+/-0.58 log10 copies/10(6) cells in 10 patients evaluated after several months of having undetectable plasma HIV RNA levels. A mean gain of 212 and 237 CD4 cells/mm3 was observed at 24 and 48 weeks, respectively. Proviral DNA sequencing showed that the main resistance codon mutations were absent in each case. Only one patient presented with a mutation resulting in the K219Q substitution, and one other with a T200I substitution. We conclude that this combination can achieve a significant decrease in HIV-1 replication in both plasma and lymph nodes in most cases. It is safe, able to delay the selection of resistant mutants, and keeps open the option for the use of protease inhibitors in case of therapeutic failure.
Collapse
Affiliation(s)
- A Lafeuillade
- Department of Infectious Diseases, General Hospital, Toulon, France.
| | | | | | | | | | | |
Collapse
|
44
|
Lafeuillade A, Chouraqui M, Hittinger G, Poggi C, Delbeke E. Lymph node expansion of CD4+ lymphocytes during antiretroviral therapy. J Infect Dis 1997; 176:1378-82. [PMID: 9359743 DOI: 10.1086/517326] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
The evolution of lymphocyte subsets was analyzed in sequential lymph nodes (LN) biopsies and compared with that in the blood of 25 human immunodeficiency virus type 1 (HIV-1)-infected patients receiving highly active antiretroviral therapy. An average of 3 biopsies were obtained from each patient, with a mean follow-up of 5.6 +/- 0.6 months. A correlation was found between the CD4:CD8 ratio in blood and in LN at baseline but not after > or = 2 months of therapy. With therapy, there was a significant increase in CD2+ cells and a much higher CD4+ cell increase and CD8+ cell decrease in LNs compared with levels in blood. A subset of patients had increased expression of Ki-67 and a decreased expression of CD8CD38 or CD3HLA-DR. Expanded CD4+ cells in LNs were mainly CD45RO+, and changes were concomitant with a decrease in LN virus load. These data demonstrate that CD4 cell reconstitution in HIV-1 infection takes place primarily in secondary lymphoid organs and is not related to a simple redistribution of cells.
Collapse
Affiliation(s)
- A Lafeuillade
- Department of Infectious Diseases, General Hospital, Toulon, France
| | | | | | | | | |
Collapse
|
45
|
Lafeuillade A, Poggi C, Tamalet C, Profizi N. Human immunodeficiency virus type 1 dynamics in different lymphoid tissue compartments. J Infect Dis 1997; 176:804-6. [PMID: 9291339 DOI: 10.1086/517307] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Human immunodeficiency virus type 1 (HIV-1) RNA was measured in total lymph node (LN) tissue and isolated LN mononuclear cells (LNMC) in sequential LN biopsy samples from 1 patient with primary HIV-1 infection and from 5 previously untreated patients with chronic disease. HIV-1 RNA levels were an average of 210-fold higher in total LN tissue compared with levels in LNMC, even during primary infection, when circulating antibodies were absent. After the patients were treated with a three- or four-drug regimen, total HIV-1 RNA decreased exponentially in total LN tissue and in LNMC (mean half-lives of 8.5 +/- 1.8 and 7.9 +/- 2.2 days, respectively). In addition, the evolution of the infectious virus in LNMC was analyzed for the 5 patients with chronic disease: Titers decreased, with a mean half-life of 7.5 +/- 2.3 days. Extracellular virions are the most important virus compartments in LNs; however, they exhibit the same dynamics as virions situated in LNMC, with a mean virus decay half-life of approximately 1 week.
Collapse
Affiliation(s)
- A Lafeuillade
- Department of Infectious Diseases, General Hospital, Toulon, France
| | | | | | | |
Collapse
|
46
|
|
47
|
Tamalet C, Lafeuillade A, Fantini J, Poggi C, Yahi N. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy. AIDS 1997; 11:895-901. [PMID: 9189215 DOI: 10.1097/00002030-199707000-00009] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
OBJECTIVE To assess the antiretroviral effect of a combination of zidovudine, didanosine, lamivudine and saquinavir in plasma, peripheral blood mononuclear cells (PBMC) and lymph-node mononuclear cells (LNMC) after 8 weeks. METHODS Ten HIV-1 antiretroviral therapy-naive patients were given a combination of oral zidovudine (200 mg three times daily), oral didanosine (200 twice a day), oral lamivudine (150 mg twice a day) and oral saquinavir (600 mg three times daily). HIV-1 plasma RNA was measured by quantitative reverse transcriptase (RT)-polymerase chain reaction (PCR). Infectious HIV-1 in PBMC and LNMC was measured by a coculture technique. HIV-1 RNA in PBMC and LNMC was quantified by RT-PCR. Proviral DNA titres in PBMC and LNMC were measured by endpoint dilution PCR. CD4 T-cells were analysed by flow cytometry. RESULTS CD4 cell counts rose in all patients (mean increase of 125 +/- 71 CD4 cells x 10(6)/l) and the benefit was greater for patients with fewer than 350 CD4 cells x 10(6)/l (mean increase of 159 +/- 74 CD4 cells x 10(6)/l). Plasma HIV-1 RNA decreased exponentially in all patients (mean decrease of 3.1 log10 after 8 weeks with a mean half-life of 2.2 +/- 0.6 days). HIV-1 RNA showed a decrease of 3.07 log10 in PBMC and of 2.1 log10 in LNMC. The decrease in plasma HIV-1 RNA was consistently associated with the decrease in LNMC. These data were supported by a concomitant drop of HIV-1 infectious titres in PBMC (mean decrease of 1.41 log10) and in LNMC (mean decrease of 2.54 log). CONCLUSIONS These data show a significant antiretroviral effect of this four-drug combination in blood and lymphoid tissues. However, a greater decrease in HIV-1 RNA was observed in PBMC and in plasma than in lymph node cells.
Collapse
Affiliation(s)
- C Tamalet
- Laboratory of Virology, Timone Hospital, Marseille, France
| | | | | | | | | |
Collapse
|
48
|
Lafeuillade A, Poggi C, Tamalet C, Profizi N, Tourres C, Costes O. Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection. J Infect Dis 1997; 175:1051-5. [PMID: 9129065 DOI: 10.1086/516442] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
A combination of zidovudine, didanosine, and lamivudine was used to treat 10 patients with primary human immunodeficiency virus type 1 (HIV-1) infection 5-28 days after the onset of symptoms. When therapy began, the mean plasma HIV-1 RNA level was 5.31 +/- 0.33 log10 copies/mL and the mean CD4 T cell count was 630 +/- 112 x 10(6)/L. The plasma HIV-1 RNA level decreased rapidly, and levels dropped below the cutoff in each case after 108 +/- 32 days. Lymph nodes from 5 patients were biopsied before therapy and during follow-up. Infectious HIV-1 could not be cultivated from any lymph node mononuclear cells taken on day 90, and HIV-1 RNA was at very low levels in lymph nodes after 1 year. In some cases, waning of the antibody response to HIV-1 was shown by Western blot after several months of undetectable plasma RNA. These data demonstrate that triple-drug therapy has a potent antiviral effect during primary HIV-1 infection.
Collapse
Affiliation(s)
- A Lafeuillade
- Department of Infectious Diseases, General Hospital, Toulon, France
| | | | | | | | | | | |
Collapse
|
49
|
Lafeuillade A, Poggi C, Sayada C, Pellegrino P, Profizi N. Focusing on the second phase of plasma HIV-1 RNA clearance. AIDS 1997; 11:264-6. [PMID: 9030385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
|
50
|
Abstract
OBJECTIVE To evaluate the antiretroviral effect of a combination of zidovudine (ZDV) and didanosine (ddl) on plasma, peripheral blood mononuclear cells (PBMC) and lymph nodes after 24 weeks. METHODS Eight patients naive of antiretroviral therapy were followed by monthly blood samples and two surgical lymph-node biopsies taken at baseline and after 24 weeks. CD4+ T cells were counted monthly by flow cytometry. Plasma HIV-1 RNA was measured monthly by polymerase chain reaction (PCR). Infectious cellular viraemia was measured monthly by a culture technique. Proviral DNA titres in PBMC were measured by endpoint dilution PCR at baseline and 24 weeks. Infectious HIV-1 and proviral DNA titres were measured in the lymph-node mononuclear cells (LNMC). The total HIV-1 RNA content of lymph nodes was measured by PCR. In some cases, phenotypic resistance to ZDV was measured, and codon 215 and 74 mutations in PBMC and LNMC were analysed. RESULTS A mean increase in CD4 cell count of 122 x 10(6)/l, a mean decrease in HIV-1 RNA of 1.47 log10 in plasma and a mean decrease in HIV-1 DNA titre of 0.63 log10 were found after 24 weeks of therapy. Nevertheless, there were no statistically significant changes in the mean infectious HIV-1 titre in PBMC and LNMC, in the HIV-1 DNA titre in LNMC or in the total lymph-node HIV-1 RNA burden at week 24. Phenotypic or genotypic markers of drug resistance were rarely found in PBMC at week 24, although they were detected in LNMC from some patients. CONCLUSION A discrepancy in the therapeutic effect can be observed between lymphoid organs and blood after 24 weeks of therapy with ZDV and ddl. This difference could be explained by the insufficient antiretroviral potency of this combination facing the significant viral burden present in lymph nodes. Development of drug resistance in this compartment prior to blood can be demonstrated in some cases, although other mechanisms remain to be investigated in future studies to explain this difference.
Collapse
Affiliation(s)
- A Lafeuillade
- Department of Infectious Diseases, General Hospital, Toulon, France
| | | | | | | | | | | |
Collapse
|